18F-fluoro-2-deoxyglucose positron emission-computed tomography in a rare cutaneous form of Rosai-Dorfman disease: A case report

Hadchiti,Joya; Kamar,Francois  G.; Abi Ghosn,Jean; Haidar,Mohamad; Younes,Ahmad; Obeid,Antoine; Haddad,Marwan; Farhat,Fadi; Chehade,Feras

doi:10.3892/mco.2017.1507

18F-fluoro-2-deoxyglucose positron emission-computed tomography in a rare cutaneous form of Rosai-Dorfman disease: A case report

Authors:
- Joya Hadchiti
- Francois G. Kamar
- Jean Abi Ghosn
- Mohamad Haidar
- Ahmad Younes
- Antoine Obeid
- Marwan Haddad
- Fadi Farhat
- Feras Chehade
View Affiliations

Affiliations: Faculty of Medical Science, Lebanese University, Hadas, Lebanon, Department of Oncology, Mount Lebanon Hospital, Beirut, Lebanon, Department of Radiology, Mount Lebanon Hospital, Beirut, Lebanon, Department of Nuclear Medicine, Mount Lebanon Hospital, Beirut, Lebanon, Department of Oncology, Central Military Hospital, Beirut, Lebanon
Published online on: November 21, 2017 https://doi.org/10.3892/mco.2017.1507
Pages: 236-241
Copyright: © Hadchiti et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Rosai-Dorfman disease (RDD), or sinus histiocytosis with massive lymphadenopathy, commonly involves the lymph nodes but may secondarily involve the skin. Purely cutaneous disease without lymphatics or internal organ involvement occurs rarely. The present report detailed a rare case of 18F-fluoro-2-deoxyglucose positron emission-computed tomography (18FDG PET-CT) performed in a 33-year-old male soldier with a purely cutaneous form of RDD. Staging with 18FDG PET-CT was ordered prior to excisional biopsies of the aforedescribed masses and pathology reported RDD. The case demonstrated accurate localization of increased radioglucose metabolism. The present case was also discussed in light of literature data in terms of clinical features, etiologies, histology, medical imaging, therapy planning and prognosis.

View Figures

View References

1	Rosai J and Dorfman RF: Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol. 87:63–70. 1969.PubMed/NCBI
2	Foucar E, Rosai J and Dorfman R: Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): Review of the entity. Semin Diagn Pathol. 7:19–73. 1990.PubMed/NCBI
3	Chappell JA, Burkemper NM, Frater JL and Hurley MY: Cutaneous rosai-dorfman disease and morphea: Coincidence or association? Am J Dermatopathol. 31:487–489. 2009. View Article : Google Scholar : PubMed/NCBI
4	Brenn T, Calonje E, Granter SR, Leonard N, Grayson W, Fletcher CD and McKee PH: Cutaneous rosai-dorfman disease is a distinct clinical entity. Am J Dermatopathol. 24:385–391. 2002. View Article : Google Scholar : PubMed/NCBI
5	Pulsoni A, Anghel G, Falcucci P, Matera R, Pescarmona E, Ribersani M, Villivà N and Mandelli F: Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): Report of a case and literature review. Am J Hematol. 69:67–71. 2002. View Article : Google Scholar : PubMed/NCBI
6	Elbuluk N, Egbers R, Taube JM and Wang TS: Cutaneous Rosai-Dorfman Disease in a Patient with Human Immunodeficiency Virus. Dermatol Online J. 22:13030/qt2162h3fj2016.PubMed/NCBI
7	Chen J, Tang H, Li B and Xiu Q: Rosai-Dorfman disease of multiple organs, including the epicardium: An unusual case with poor prognosis. Heart Lung. 40:168–171. 2011. View Article : Google Scholar : PubMed/NCBI
8	Ottaviano G, Doro D, Marioni G, Mirabelli P, Marchese-Ragona R, Tognon S, Marino F and Staffieri A: Extranodal Rosai-Dorfman disease: Involvement of eye, nose and trachea. Acta Otolaryngol. 126:657–660. 2006. View Article : Google Scholar : PubMed/NCBI
9	Dalia S, Sagatys E, Sokol L and Kubal T: Rosai-Dorfman Disease: Tumor Biology, Clinical Features, Pathology, and Treatment Cancer Control. October;2014.21(4)
10	McClain KL, Natkunam Y and Swerdlow SH: Atypical cellular disorders. Hematology (Am Soc Hematol Educ Program). 2004:283–296. 2004.
11	La Barge DV III, Salzman KL, Harnsberger HR, Ginsberg LE, Hamilton BE, Wiggins RH III and Hudgins PA: Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): Imaging manifestations in the head and neck. AJR Am J Roentgenol. 191:W299–306. 2008. View Article : Google Scholar : PubMed/NCBI
12	Zaveri J, La Q, Yarmish G and Neuman J: More than just Langerhans cell histiocytosis: A radiologic review of histiocytic disorders. Radiographics. 34:2008–2024. 2014. View Article : Google Scholar : PubMed/NCBI
13	Yu JQ, Zhuang H, Xiu Y, Talati E and Alavi A: Demonstration of increased FDG activity in Rosai-Dorfman disease on positron emission tomography. Clin Nucl Med. 29:209–210. 2004. View Article : Google Scholar : PubMed/NCBI
14	Mosheimer BA, Oppl B, Zandieh S, Fillitz M, Keil F, Klaushofer K, Weiss G and Zwerina J: Bone Involvement in Rosai-Dorfman Disease (RDD): A Case Report and Systematic Literature Review. Curr Rheumatol Rep. 19:292017. View Article : Google Scholar : PubMed/NCBI
15	Thawerani H, Sanchez RL, Rosai J and Dorfman RF: The cutaneous manifestations of sinus histiocytosis with massive lymphadenopathy. Arch Dermatol. 114:191–197. 1978. View Article : Google Scholar : PubMed/NCBI
16	Wang KH, Chen WY, Liu HN, Huang CC, Lee WR and Hu CH: Cutaneous Rosai-Dorfman disease: Clinicopathological profiles, spectrum and evolution of 21 lesions in six patients. Br J Dermatol. 154:277–286. 2006. View Article : Google Scholar : PubMed/NCBI
17	Cole S and Finlay J: 2-Chlorodeoxyadenosine for adults with multi-system Langerhans cell histiocytosis. Med Pediatr Oncol. 33:5121999.
18	Rubenstein MA, Farnsworth NN, Pielop JA, Orengo IF, Curry JL, Drucker CR and Hsu S: Cutaneous Rosai-Dorfman disease. Dermatol Online J. 12:82006.PubMed/NCBI
19	Hervier B, Haroche J, Arnaud L, Charlotte F, Donadieu J, Néel A, Lifermann F, Villabona C, Graffin B, Hermine O, et al French Histiocytoses Study Group, : Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. Blood. 124:1119–1126. 2014. View Article : Google Scholar : PubMed/NCBI
20	Weitzman S and Jaffe R: Uncommon histiocytic disorders: The non-Langerhans cell histiocytoses. Pediatr Blood Cancer. 45:256–264. 2005. View Article : Google Scholar : PubMed/NCBI
21	Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, et al Histiocyte Society, : Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 127:2672–2681. 2016. View Article : Google Scholar : PubMed/NCBI
22	O'Malley DP, Duong A, Barry TS, Chen S, Hibbard MK, Ferry JA, Hasserjian RP, Thompson MA, Richardson MS, Jaffe R, et al: Co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: Possible relationship of two histiocytic disorders in rare cases. Mod Pathol. 23:1616–1623. 2010. View Article : Google Scholar : PubMed/NCBI
23	Juskevicius R and Finley JL: Rosai-Dorfman disease of the parotid gland: Cytologic and histopathologic findings with immunohistochemical correlation. Arch Pathol Lab Med. 125:1348–1350. 2001.PubMed/NCBI
24	Kong YY, Kong JC, Shi DR, Lu HF, Zhu XZ, Wang J and Chen ZW: Cutaneous rosai-dorfman disease: A clinical and histopathologic study of 25 cases in China. Am J Surg Pathol. 31:341–350. 2007. View Article : Google Scholar : PubMed/NCBI
25	Bonetti F, Chilosi M, Menestrina F, Scarpa A, Pelicci PG, Amorosi E, Fiore-Donati L and Knowles DM II: Immunohistological analysis of Rosai-Dorfman histiocytosis. A disease of S-100 + CD1-histiocytes. Virchows Arch A Pathol Anat Histopathol. 411:129–135. 1987. View Article : Google Scholar : PubMed/NCBI
26	Ying M, Ahuja AT and Yuen HY: Grey-scale and power Doppler sonography of unusual cervical lymphadenopathy. Ultrasound Med Biol. 30:449–454. 2004. View Article : Google Scholar : PubMed/NCBI
27	Karunanithi S, Singh H, Sharma P, Naswa N and Kumar R: 18F-FDG PET/CT imaging features of Rosai Dorfman disease: A rare cause of massive generalized lymphadenopathy. Clin Nucl Med. 39:268–269. 2014. View Article : Google Scholar : PubMed/NCBI
28	Tsang JS, Anthony MP, Wong MP and Wong CS: The use of FDG-PET/CT in extranodal Rosai-Dorfman disease of bone. Skeletal Radiol. 41:715–717. 2012. View Article : Google Scholar : PubMed/NCBI
29	Albano D, Bosio G and Bertagna F: 18F-FDG PET/CT follow-up of Rosai-Dorfman disease. Clin Nucl Med. 40:e420–e422. 2015. View Article : Google Scholar : PubMed/NCBI
30	Ha H, Kim KH, Ahn YJ, Kim JH, Kim JE and Yoon S-S: A rare case of Rosai-Dorfman disease without lymphadenopathy. Korean J Intern Med. 31:802–804. 2016. View Article : Google Scholar : PubMed/NCBI
31	Shaikh F, Awan O, Mohiuddin S, Farooqui S, Khan SA and McCartney W: 18F-FDG PET/CT Imaging of Extranodal Rosai-Dorfman Disease with Hepatopancreatic Involvement - A Pictorial and Literature Review. Cureus. 7:e3922015.PubMed/NCBI
32	Liu B, Lee NJ, Otero HJ, Servaes S and Zhuang H: Rosai-Dorfman disease mimics lymphoma on FDG PET/CT in a pediatric patient. Clin Nucl Med. 39:206–208. 2014.PubMed/NCBI
33	Deshayes E, Le Berre JP, Jouanneau E, Vasiljevic A, Raverot G and Seve P: 18F-FDG PET/CT findings in a patient with isolated intracranial Rosai-Dorfman disease. Clin Nucl Med. 38:e50–e52. 2013. View Article : Google Scholar : PubMed/NCBI
34	Le Guenno G, Galicier L, Uro-Coste E, Petitcolin V, Rieu V and Ruivard M: Successful treatment with azathioprine of relapsing Rosai-Dorfman disease of the central nervous system. J Neurosurg. 117:486–489. 2012. View Article : Google Scholar : PubMed/NCBI
35	Huang JY, Lu CC, Hsiao CH and Tzen KY: FDG PET/CT findings in purely cutaneous Rosai-Dorfman disease. Clin Nucl Med. 36:e13–e15. 2011. View Article : Google Scholar : PubMed/NCBI
36	Madhunapantula SV, Gowda R, Inamdar GS and Robertson GP: In situ photoimmunotherapy: A new hope for cutaneous melanoma patients. Cancer Biol Ther. 10:1088–1090. 2010. View Article : Google Scholar : PubMed/NCBI
37	Adeleye AO, Amir G, Fraifeld S, Shoshan Y, Umansky F and Spektor S: Diagnosis and management of Rosai-Dorfman disease involving the central nervous system. Neurol Res. 32:572–578. 2010. View Article : Google Scholar : PubMed/NCBI
38	Li M, Shi L, Luo M, Chen J, Wang B, Zhang F, Keyal U, Bhatta AK, Chen WR and Wang X: Successful treatment of Rosai-Dorfman disease using in situ photoimmunotherapy. Indian J Dermatol Venereol Leprol. 83:332–336. 2017. View Article : Google Scholar : PubMed/NCBI
39	Lu LY, Ju WT, Cai M and Lu XF: Cutaneous Rosai-Dorfman disease recurrence in infraorbital region. J Craniofac Surg. 23:e509–e510. 2012. View Article : Google Scholar : PubMed/NCBI
40	Dalia S, Sagatys E, Sokol L and Kubal T: Rosai-Dorfman disease: Tumor biology, clinical features, pathology, and treatment. Cancer Control. 21:322–327. 2014. View Article : Google Scholar : PubMed/NCBI